Poolbeg Pharma (POLB), a clinical stage infectious disease pharmaceutical company, updated on the strengthening of its intellectual property (IP) position around POLB 001, a small molecule immunomodulator for the treatment of severe influenza.
The company said it is continuing to expand its global patent protection for its growing pipeline of infectious disease products. It is delighted to receive confirmation from the US Patent and Trademarks office that the main claim is allowable, and looks forward to updating the market when it receives the formal patent grant in due course.
Labskin, a DeepVerge (DVRG) business, announced its selection by the Intelligence Advanced Research Projects Activity, part of the US Office of the Director of National Intelligence, to join a team of experts to develop new ways to evaluate radiation exposure in civilians and military personnel. Labskin is a key member of a consortium selected to develop these technologies in collaboration with a multidisciplinary team of experts in the US. The three year project is worth $810,000 to Labskin.
Tirupati Graphite (TGR) announced that holders of the convertible loan notes of par value £1.00 each issued by Tirupati on 17 May 2019 have elected to convert 100,000 CLN’s into 222,222 ordinary shares of 2.5 pence each, at the Company’s IPO price in accordance with the instrument, being a price of 45 pence each in the share capital of Tirupati.
Synairgen (SNG), the respiratory company developing SNG001, announced topline data for participants treated with SNG001 in the US National Institutes of Health (NIH)/ AIDS Clinical Trials Group (ACTG)-led ACTIV-2 Phase 2 adaptive platform trial for COVID-19. The company said the data from the ACTIV-2 trial in the US showed non-significant but encouraging 86% relative risk reduction in hospitalisation following treatment with SNG001 in home-based patients. This is very interesting when considered in the context of therapeutic options for the management of non-hospitalised patients during a pandemic.
Kazera Global plc (KZG), the AIM quoted investment company, announce that Align Research has today released research coverage on the Company. Align Research have set a target price of 4.55p and reiterated their Conviction Buy stance. The note covers the potential of the tantalum and lithium mine to be unlocked, the production potential of Heavy Mineral Sands (HMS), the REE project acquisition, and risked conservative NPV suggesting upside of close to more than 500% among other analysis of the portfolio.
First Class Metals (FCM) the UK metals exploration company, provided information on a potential acquisition transaction with Nuinsco Resources Limited for the ‘Sunbeam Project’ in Ontario. The company said This is a very positive, significant development for FCM, the purchase of Sunbeam presents an opportunity to develop a historical high grade gold mine.
Eco Atlantic (ECO), the oil and gas exploration company, announced the arrival of the Island Innovator Semi-Submersible Drilling Rig on Block 2B and the commencement of operations of the Gazania-1 Exploration Well. Eco holds a 50% Working Interest in Block 2B and is Operator of the block. The Gazania-1 Prospect is targeting over 300 million barrels of light oil.
N4 Pharma (N4P), the specialist pharmaceutical company developing Nuvec®, announced successful in vitro testing of Nuvec® loaded with two small interfering RNA (siRNA) probes. The company said showing that Nuvec® loaded with two generic siRNA probes still achieves significant silencing of their respective genes is validation for it to now begin the further work that was announced on 14 September with EGFR and BCl-2 in a PC9 lung cancer model.
Union Jack Oil (UJO) a UK focused onshore hydrocarbon company, announced that material landmark net revenues of $10,000,000 have been achieved from the Wressle hydrocarbon development, located within licences PEDL180 and PEDL182 in North Lincolnshire on the western margin of the Humber Basin. Union Jack holds a 40% economic interest in this development.
WANdisco (WAND), the data activation platform, announced that it has signed a follow-on agreement worth $7.1 million with a large European automotive components supplier. The Client initially entered into a Commit-to-Consume contract with WANdisco valued at a minimum of $5 million over five years.
Marula Mining (MARU), an African focused mining investment company, announced that it has entered into a binding heads of agreement with Tanzanian mining company, Takela Mining Tanzania Limited, and have secured a 49% commercial interest in the Kinusi Copper Mining Project which comprise 10 granted copper mining licences located in Tanzania.
Disclaimer & Declaration of Interest
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.
